首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

2055329

血液培養檢測市場：依檢測方法、產品、技術、應用、最終用戶和地區分類

Blood Culture Test Market, By Method, By Product, By Technology, By Application, By End User, By Geography

出版日期: 2026年03月10日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，血液培養檢測市場規模將達到72.9億美元，到2033年將達到156.2億美元。預計從2026年到2033年，該市場將以11.5%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	72.9億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	11.50%	2033年市場規模預測：	156.2億美元

全球血液培養檢測市場是診斷醫療醫療產業的關鍵領域，也是檢測和識別血液感染疾病、敗血症和菌血症的基礎。

血液培養檢測是指採集患者血液樣本，並將其置於專門的培養基中進行培養，以檢測血液中是否有細菌、真菌和酵母等致病微生物。隨著技術的進步，這種調查方法已發生顯著變化，從傳統的手動操作轉變為自動化系統，從而提高了準確性，縮短了結果週轉時間，並改善了臨床療效。

該市場涵蓋多種調查方法，例如傳統培養方法、自動化血液培養系統和分子診斷技術。全球醫療機構高度依賴血液培養檢測，以獲取選擇合適的抗生素療法和患者管理策略所需的重要資訊。

隨著醫院感染病例的增加、人們對早期診斷膿毒症重要性的認知不斷提高，以及對合理使用抗生素方案的日益重視，血液培養檢測已成為現代醫學中不可或缺的工具。該市場涵蓋眾多相關人員，包括診斷檢查室、醫院、血庫和研究機構，所有這些機構都推動了對可靠且高效的血液培養檢測解決方案日益成長的需求。

市場動態

全球血液培養檢測市場的成長受到多個強勁因素的推動，這些因素正推動其整體成長動能。其中一個關鍵因素是全球血液感染疾病和敗血症發病率的上升，這刺激了對快速、準確診斷解決方案的需求。醫院感染的增加，以及因癌症治療、器官移植和慢性疾病導致免疫力缺乏患者數量的增加，都創造了巨大的市場需求。自動化血液培養系統的技術進步，提高了檢測速度和靈敏度，是推動市場成長的關鍵因素。

此外，老年人口的增加以及易感感染疾病的增加和外科手術數量的上升也促進了市場成長。然而，該市場也存在一些限制因素。自動化血液培養系統及其維護高成本，可能會阻礙其在資源有限的醫療機構中的應用。血液培養操作複雜，需要熟練的技術人員，且有因污染導致假陽性結果的風險，這些都構成了進一步的挑戰。診斷設備嚴格的監管要求以及傳統培養方法的耗時性也可能成為阻礙市場成長的因素。

儘管如此，開發能夠在數小時而非數天內得出結果的快速分子診斷技術和就地檢驗解決方案仍蘊藏著巨大的機會。新興市場醫療基礎設施的不斷改善、醫療成本的不斷上漲以及對個人化醫療日益成長的關注，都創造了盈利的市場機會。將人工智慧 (AI) 和機器學習技術整合到血液培養系統中以提高結果的可解讀性，以及開發用於同時檢測多種病原體的多檢測平台，都預示著市場擴張的廣闊前景。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球血液培養檢測市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球血液培養檢測市場報告的目標對象包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業相關人員相關者。
相關人員可以透過利用全球血液培養檢測市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Becton, Dickinson and Company（BD）
bioMerieux SA
Thermo Fisher Scientific Inc.
Danaher Corporation
Roche Diagnostics
Siemens Healthineers AG
Abbott Laboratories
Bruker Corporation
T2 Biosystems Inc.
Cepheid Inc.
Luminex Corporation
Merck KGaA（MilliporeSigma）
Sartorius AG
QIAGEN NV
BioFire Diagnostics LLC

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8499

Blood Culture Test Market is estimated to be valued at USD 7.29 Bn in 2026 and is expected to reach USD 15.62 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 7.29 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	11.50%	2033 Value Projection:	USD 15.62 Bn

The global blood culture test market represents a critical segment within the diagnostic healthcare industry, serving as a cornerstone for detecting and identifying bloodstream infections, sepsis, and bacteremia.

Blood culture testing involves the collection of blood samples from patients and their cultivation in specialized media to detect the presence of pathogenic microorganisms, including bacteria, fungi, and yeasts that may be circulating in the bloodstream. This diagnostic methodology has evolved significantly with technological advancements, transitioning from traditional manual methods to automated systems that offer enhanced accuracy, reduced time-to-results, and improved clinical outcomes.

The market encompasses various testing methodologies, including conventional culture methods, automated blood culture systems, and molecular diagnostic techniques. Healthcare facilities worldwide rely heavily on blood culture testing as it provides crucial information for appropriate antibiotic therapy selection and patient management strategies.

The increasing prevalence of hospital-acquired infections, rising awareness about early diagnosis of sepsis, and growing emphasis on antimicrobial stewardship programs have positioned blood culture testing as an indispensable tool in modern healthcare. The market includes various stakeholders such as diagnostic laboratories, hospitals, blood banks, and research institutions, all contributing to the expanding demand for reliable and efficient blood culture testing solutions.

Market Dynamics

The global blood culture test market growth is driven by several compelling factors that collectively propel its growth trajectory. The primary driver is the escalating incidence of bloodstream infections and sepsis globally, which has intensified the demand for rapid and accurate diagnostic solutions. The increasing prevalence of hospital-acquired infections, coupled with the growing number of immunocompromised patients due to cancer treatments, organ transplants, and chronic diseases, has created a substantial market demand. Technological advancements in automated blood culture systems, offering faster detection times and improved sensitivity, serve as significant growth catalysts.

Additionally, the growing geriatric population, which is more susceptible to infections, and the increasing number of surgical procedures contribute to market growth. However, the market faces certain restraints including the high cost of automated blood culture systems and their maintenance, which can limit adoption in resource-constrained healthcare settings. The complexity of blood culture procedures requiring skilled laboratory personnel and the risk of contamination leading to false-positive results pose additional challenges. Stringent regulatory requirements for diagnostic devices and the time-consuming nature of traditional culture methods can also impede market growth.

Nevertheless, significant opportunities exist in the development of rapid molecular diagnostic techniques and point-of-care testing solutions that can deliver results within hours rather than days. The expansion of healthcare infrastructure in emerging markets, increasing healthcare expenditure, and the growing focus on personalized medicine present lucrative opportunities. The integration of artificial intelligence and machine learning in blood culture systems for enhanced interpretation and the development of multiplex testing platforms for simultaneous detection of multiple pathogens represent promising avenues for market expansion.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood culture test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Becton, Dickinson and Company (BD), bioMerieux S.A., Thermo Fisher Scientific Inc., Danaher Corporation, Roche Diagnostics, Siemens Healthineers AG, Abbott Laboratories, Bruker Corporation, T2 Biosystems Inc., Cepheid Inc., Luminex Corporation, Merck KGaA (MilliporeSigma), Sartorius AG, QIAGEN N.V., and BioFire Diagnostics LLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood culture test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood culture test market

Market Segmentation

Method Insights (Revenue, USD Bn, 2021 - 2033)
Automated Blood Culture
Conventional/Manual Blood Culture
Product Insights (Revenue, USD Bn, 2021 - 2033)
Consumables (e.g., Media, Assay kits and reagents, accessories, etc.)
Instruments (Automated blood culture systems, laboratory equipment)
Software and Services
Technology Insights (Revenue, USD Bn, 2021 - 2033)
Culture-Based Technologies (including conventional, resin-based)
Molecular Technologies (NAAT, PCR-based panels, Microarrays)
Proteomic Technologies (MALDI-TOF, LC-MS)
Application Insights (Revenue, USD Bn, 2021 - 2033)
Bacterial Infections (e.g., bacteremia, septicemia)
Fungal Infections (e.g., fungemia)
Mycobacterial Infections
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospital Laboratories
Diagnostic Laboratories
Academic and Research Institutes
Others (Pathology labs, Bacteriological labs, independent research labs, ambulatory surgery centers)
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Becton, Dickinson and Company (BD)
bioMerieux S.A.
Thermo Fisher Scientific Inc.
Danaher Corporation
Roche Diagnostics
Siemens Healthineers AG
Abbott Laboratories
Bruker Corporation
T2 Biosystems Inc.
Cepheid Inc.
Luminex Corporation
Merck KGaA (MilliporeSigma)
Sartorius AG
QIAGEN N.V.
BioFire Diagnostics LLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Blood Culture Test Market, By Method
- Global Blood Culture Test Market, By Product
- Global Blood Culture Test Market, By Technology
- Global Blood Culture Test Market, By Application
- Global Blood Culture Test Market, By End User
- Global Blood Culture Test Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Blood Culture Test Market, By Method, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Automated Blood Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Conventional/Manual Blood Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Blood Culture Test Market, By Product, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Consumables (e.g., Media, Assay kits and reagents, accessories, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Instruments (Automated blood culture systems, laboratory equipment)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Blood Culture Test Market, By Technology, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Culture-Based Technologies (including conventional, resin-based)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Molecular Technologies (NAAT, PCR-based panels, Microarrays)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Proteomic Technologies (MALDI-TOF, LC-MS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Blood Culture Test Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Bacterial Infections (e.g., bacteremia, septicemia)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Fungal Infections (e.g., fungemia)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Mycobacterial Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Blood Culture Test Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others (Pathology labs, Bacteriological labs, independent research labs, ambulatory surgery centers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Blood Culture Test Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Becton, Dickinson and Company (BD)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
bioMerieux S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bruker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
T2 Biosystems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cepheid Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Luminex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA (MilliporeSigma)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sartorius AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioFire Diagnostics LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies